Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to Internal Medicine

Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-label Non-randomized Clinical Trial

Allergy & Immunology March 30th 2020

Tags: COVID-19

PODCAST: Cancer Center Preparedness for the COVID-19 Pandemic

Allergy & Immunology March 23rd 2020

Tags: COVID-19

NCCN Publishes Guidance for Cancer Centers During COVID-19 Pandemic

Hematology March 23rd 2020

Tags: COVID-19

COVID-19 and Cancer

Hematology March 23rd 2020

Tags: COVID-19

The New England Journal of Medicine

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

Internal Medicine March 16th 2020

The New England Journal of Medicine

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

Hematology March 16th 2020

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form